C. Wu

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Lynn G. Feun, Angela Marini, Gail Walker et al. · British Journal of Cancer · 2012 · 113 citations · Full text

Medicine, Clinical Sciences, Oncology +15

Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer

M Wangpaichitr, Y Y Li, C. Wu et al. · Cell & Developmental Biology · 2017 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux.

Danièle Brouty‐Boyé, Despina S. Kolonias, C. Wu et al. · PubMed · 1995 · 25 citations

Medicine, Oncology, Pharmacology +11

Final results of phase II trial of pegylated arginine deiminase (ADI-PEG20) in metastatic melanoma (MM).

Lynn G. Feun, Ming You, C. Wu et al. · Journal of Clinical Oncology · 2010 · 10 citations

Medicine, Oncology, Pharmacology +17